289
Views
21
CrossRef citations to date
0
Altmetric
Articles

Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE‐related cardiovascular disease

, , , , , , & show all
Pages 184-189 | Accepted 09 Oct 2008, Published online: 13 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

K Eriksson, E Svenungsson, H Karreskog, I Gunnarsson, J Gustafsson, S Möller, S Pettersson & C Boström. (2012) Physical activity in patients with systemic lupus erythematosus and matched controls. Scandinavian Journal of Rheumatology 41:4, pages 290-297.
Read now
Samuel O Olusi & Sunila George. (2011) Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus. Vascular Health and Risk Management 7, pages 75-80.
Read now
P Szodoray, T Tarr, A Bazso, G Poor, G Szegedi & E Kiss. (2011) The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scandinavian Journal of Rheumatology 40:2, pages 122-126.
Read now

Articles from other publishers (17)

Rahmah Alghareeb, Afshan Hussain, Marvi V Maheshwari, Nabeeha Khalid & Pragnesh D Patel. (2022) Cardiovascular Complications in Systemic Lupus Erythematosus. Cureus.
Crossref
George A. Robinson, Ines Pineda-Torra, Coziana Ciurtin & Elizabeth C. Jury. (2022) Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk. Frontiers in Medicine 9.
Crossref
Karen Pesqueda-Cendejas, Isela Parra-Rojas, Paulina E. Mora-García, Margarita Montoya-Buelna, Adolfo I. Ruiz-Ballesteros, Mónica R. Meza-Meza, Bertha Campos-López, Melissa Rivera-Escoto, Barbara Vizmanos-Lamotte, Sergio Cerpa-Cruz & Ulises de la Cruz-Mosso. (2022) CRP Serum Levels Are Associated with High Cardiometabolic Risk and Clinical Disease Activity in Systemic Lupus Erythematosus Patients. Journal of Clinical Medicine 11:7, pages 1849.
Crossref
Fabrizia Bonacina, Angela Pirillo, Alberico L. Catapano & Giuseppe D. Norata. (2021) HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases. Cells 10:5, pages 1061.
Crossref
Shiva Ganjali, Leila Shirmohammadi, Morgayn I Read & Amirhossein Sahebkar. (2020) High-density lipoprotein functionality in systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 50:4, pages 769-775.
Crossref
Pavel Kraml. (2020) Lipid-lowering therapy in selected specific groups of patients. Medicína pro praxi 17:3, pages 151-156.
Crossref
Sang Yeop Kim, Minzhi Yu, Emily E. Morin, Jukyung Kang, Mariana J. Kaplan & Anna Schwendeman. (2019) High‐Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy. Arthritis & Rheumatology 72:1, pages 20-30.
Crossref
Krisztina Gaál, Tünde Tarr, Hajnalka Lőrincz, Viktor Borbás, Ildikó Seres, Mariann Harangi, Péter Fülöp & György Paragh. (2016) High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Lipids in Health and Disease 15:1.
Crossref
Malcolm Anastasius, Maaike Kockx, Wendy Jessup, David Sullivan, Kerry-Anne Rye & Leonard Kritharides. (2016) Cholesterol efflux capacity: An introduction for clinicians. American Heart Journal 180, pages 54-63.
Crossref
Konstantinos Tselios, Charalambos Koumaras, Dafna D. Gladman & Murray B. Urowitz. (2016) Dyslipidemia in systemic lupus erythematosus: just another comorbidity?. Seminars in Arthritis and Rheumatism 45:5, pages 604-610.
Crossref
Fabrizio Montecucco, Elda Favari, Giuseppe Danilo Norata, Nicoletta Ronda, Jerzy-Roch Nofer & Nicolas Vuilleumier. 2015. High Density Lipoproteins. High Density Lipoproteins 455 482 .
Nicoletta Ronda, Elda Favari, Maria Orietta Borghi, Francesca Ingegnoli, Maria Gerosa, Cecilia Chighizola, Francesca Zimetti, Maria Pia Adorni, Franco Bernini & Pier Luigi Meroni. (2014) Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus. Annals of the Rheumatic Diseases 73:3, pages 609-615.
Crossref
?scar P?rez-M?ndez, H?ctor Gonz?lez Pacheco, Carlos Mart?nez-S?nchez & Martha Franco. (2014) HDL-cholesterol in coronary artery disease risk: Function or structure?. Clinica Chimica Acta 429, pages 111-122.
Crossref
Jun HaoYu-jun ZhangXin LvNing XuQin-juan LiuSong ZhaoXiao-juan FengLing-ling Xing, Peng-peng KangGui-ying Li & Shu-xia Liu. (2013) IFN-γ induces lipogenesis in mouse mesangial cells via the JAK2/STAT1 pathway. American Journal of Physiology-Cell Physiology 304:8, pages C760-C767.
Crossref
Pál Soltész, György Kerekes, Henriett Dér, Gabriella Szücs, Sándor Szántó, Emese Kiss, Edit Bodolay, Margit Zeher, Orsolya Timár, Péter Szodoray, Gyula Szegedi & Zoltán Szekanecz. (2011) Comparative assessment of vascular function in autoimmune rheumatic diseases: Considerations of prevention and treatment. Autoimmunity Reviews 10:7, pages 416-425.
Crossref
Carly Skamra & Rosalind Ramsey-Goldman. (2010) Management of cardiovascular complications in systemic lupus erythematosus. International Journal of Clinical Rheumatology 5:1, pages 75-100.
Crossref
Rina Mina & Hermine I. Brunner. (2010) Pediatric Lupus—Are There Differences in Presentation, Genetics, Response to Therapy, and Damage Accrual Compared with Adult Lupus?. Rheumatic Disease Clinics of North America 36:1, pages 53-80.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.